Kendra Adams

CIK: 0001991929

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)6 (35.3%)

Derivative conversions

Awards (A)2 (11.8%)

Compensation grants

Other (G, F, J, C, D, …)9 (52.9%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CCCC

C4 Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (17 total)

CCCC
C4 Therapeutics, Inc.
Sep 18, 2026
Exercise(M)
Direct
6.3K shares-
CCCC
C4 Therapeutics, Inc.
Sep 18, 2026
Tax Payment(F)
Direct
2.8K shares at avg. $3.39$9K
CCCC
C4 Therapeutics, Inc.
Feb 14, 2026
Exercise(M)
Direct
31K shares-
CCCC
C4 Therapeutics, Inc.
Feb 14, 2026
Tax Payment(F)
Direct
15.4K shares at avg. $1.89$29K
CCCC
C4 Therapeutics, Inc.
Feb 13, 2026
Award(A)
Direct
240K shares-
CCCC
C4 Therapeutics, Inc.
Feb 13, 2026
Exercise(M)
Direct
3.8K shares-
CCCC
C4 Therapeutics, Inc.
Feb 13, 2026
Tax Payment(F)
Direct
1.9K shares at avg. $1.89$4K
CCCC
C4 Therapeutics, Inc.
Sep 18, 2025
Tax Payment(F)
Direct
2.8K shares at avg. $3.32$9K
CCCC
C4 Therapeutics, Inc.
Sep 18, 2025
Exercise(M)
Direct
6.3K shares-
CCCC
C4 Therapeutics, Inc.
Feb 14, 2025
Tax Payment(F)
Direct
4.6K shares at avg. $3.18$14K
CCCC
C4 Therapeutics, Inc.
Feb 14, 2025
Award(A)
Direct
87.1K shares-
CCCC
C4 Therapeutics, Inc.
Feb 13, 2025
Tax Payment(F)
Direct
1.9K shares at avg. $3.20$6K
CCCC
C4 Therapeutics, Inc.
Nov 7, 2024
Exercise(M)
Direct
3.8K shares-
CCCC
C4 Therapeutics, Inc.
Nov 7, 2024
Tax Payment(F)
Direct
1.1K shares at avg. $6.04$7K
CCCC
C4 Therapeutics, Inc.
Sep 18, 2024
Tax Payment(F)
Direct
1.8K shares at avg. $6.38$12K
CCCC
C4 Therapeutics, Inc.
Sep 16, 2024
Exercise(M)
Direct
2.3K shares-
CCCC
C4 Therapeutics, Inc.
Sep 16, 2024
Tax Payment(F)
Direct
661 shares at avg. $6.36$4K

		Type	Shares	Price		Ownership
Sep 18, 2026	CCCC C4 Therapeutics, Inc.	Exercise(M)	6,250	-	$0	Direct
Sep 18, 2026	CCCC C4 Therapeutics, Inc.	Tax Payment(F)	2,775	$3.39	$9,407	Direct
Feb 14, 2026	CCCC C4 Therapeutics, Inc.	Exercise(M)	30,950	-	$0	Direct
Feb 14, 2026	CCCC C4 Therapeutics, Inc.	Tax Payment(F)	15,381	$1.89	$29,070	Direct
Feb 13, 2026	CCCC C4 Therapeutics, Inc.	Award(A)	240,000	-	$0	Direct
Feb 13, 2026	CCCC C4 Therapeutics, Inc.	Exercise(M)	3,750	-	$0	Direct
Feb 13, 2026	CCCC C4 Therapeutics, Inc.	Tax Payment(F)	1,863	$1.89	$3,521	Direct
Sep 18, 2025	CCCC C4 Therapeutics, Inc.	Tax Payment(F)	2,775	$3.32	$9,213	Direct
Sep 18, 2025	CCCC C4 Therapeutics, Inc.	Exercise(M)	6,250	-	-	Direct
Feb 14, 2025	CCCC C4 Therapeutics, Inc.	Tax Payment(F)	4,559	$3.18	$14,498	Direct
Feb 14, 2025	CCCC C4 Therapeutics, Inc.	Award(A)	87,100	-	-	Direct
Feb 13, 2025	CCCC C4 Therapeutics, Inc.	Tax Payment(F)	1,863	$3.20	$5,962	Direct
Nov 7, 2024	CCCC C4 Therapeutics, Inc.	Exercise(M)	3,750	-	$0	Direct
Nov 7, 2024	CCCC C4 Therapeutics, Inc.	Tax Payment(F)	1,102	$6.04	$6,656	Direct
Sep 18, 2024	CCCC C4 Therapeutics, Inc.	Tax Payment(F)	1,837	$6.38	$11,720	Direct
Sep 16, 2024	CCCC C4 Therapeutics, Inc.	Exercise(M)	2,250	-	$0	Direct
Sep 16, 2024	CCCC C4 Therapeutics, Inc.	Tax Payment(F)	661	$6.36	$4,204	Direct

1-17 of 17 transactions

About Adams Kendra

Adams Kendra (SEC CIK 0001991929) files insider reports with the SEC as Chief Financial Officer of C4 Therapeutics, Inc. (CCCC).

Signal8 holds 7 ownership filings by Adams Kendra, all Form 4s, filed between Sep 17, 2024 and Sep 21, 2026. Those filings report 17 transactions, from Sep 16, 2024 to Sep 18, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Adams Kendra's filings is in WATERTOWN, MA.

Recent filings by Adams Kendra

Sep 18, 2026: Option exercise of CCCC shares (Form 4, code M).
Sep 18, 2026: Tax withholding of CCCC shares (Form 4, code F).
Feb 14, 2026: Option exercise of CCCC shares (Form 4, code M).
Feb 14, 2026: Tax withholding of CCCC shares (Form 4, code F).
Feb 13, 2026: Grant or award of CCCC shares (Form 4, code A).

Other insiders filing for C4 Therapeutics, Inc. (CCCC)

Anderson Kenneth Carl, Director
GROGAN DONNA ROY, Director
REYNO LEONARD, Chief Medical Officer
Hughes Owen, Director
Hoerter Steven L., Director
Koppikar Utpal, Director

How to read Form 4 transaction codes